It belongs to a novel class of agents known as triple hormone receptor agonists, meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Orforglipron is a once-daily, orally administered, non-peptide GLP-1 receptor agonist that operates in a slightly different manner from natural GLP-1
Some hormonal IUDs can cause changes in your period, such as lighter bleeding or no bleeding at all
By acting like the hormone GLP-1, it helps control blood sugar levels, reduces hunger, and promotes a feeling of fullness
Brunner said the Alliance for Pharmacy Compounding provides a link on its website that allows patients to find a state-licensed pharmacy in the state they live in